Nomura Holdings
LAB icon

Nomura Holdings’s Standard BioTools LAB Stock Holding History

Nomura Holdings’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-30,000
Closed -$181K – 2115
2020
Q4 		$181K Buy
+30,000
New +$197K ﹤0.01% 1390
2013
Q4 		– Sell
-10,318
Closed -$226K – 2166
2013
Q3 		$226K Sell
10,318
-6,253
-38% -$123K ﹤0.01% 1840
2013
Q2 		$291K Buy
+16,571
New +$291K ﹤0.01% 1621

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Nomura Holdings's LAB Position: Q1 2021 in Review

Nomura Holdings sold out of Standard BioTools (LAB) in Q1 2021, closing a stake of 30,000 shares — an estimated $181K sold.

Nomura Holdings first reported a position in LAB in Q2 2013 and held it in 3 quarters. The position peaked at $291K in Q2 2013. 138 funds tracked by Wall St. Rank hold LAB as of Q1 2021.

  • Nomura Holdings reported no remaining Standard BioTools position as of Q1 2021 after selling out during the quarter.
  • Nomura Holdings sold 30,000 Standard BioTools shares in Q1 2021, an estimated $181K.
  • Nomura Holdings first reported a position in Standard BioTools in Q2 2013 and held it in 3 quarters.
  • Nomura Holdings's Standard BioTools position peaked at $291K in Q2 2013.
  • 138 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2021.

Based on Nomura Holdings's 13F filing for Q1 2021, filed 17 May 2021.